Asceniv
Asceniv (immune globulin intravenous, human-slra) is a prescription medicine to help adults and adolescents (12 to 17 years old) with primary immunodeficiency fight and prevent infections. ASCENIV™ is the only available IVIG product made with ADMA Biologics’ proprietary method for donor screening & plasma pooling.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
MANUFACTURER: ADMA Biologic |
CLASS: Immune globulins (blood products) |
WHAT IT TREATS: Primary Immunodeficiency Syndrome (PI), Immune Thrombocytopenic Purpura (ITP), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Bone Marrow Transplant, B-cell Chronic Lymphocytic Leukemia, Multifocal Motor Neuropathy, and Dermatomyositis. |
PRESCRIBED BY: Neurologists |
HOW ADMINISTERED: Infusion |
FREQUENCY: Every 3-4 weeks |
Length of infusion: One hour to several hours depending on the dose |
FOR MORE INFORMATION: Asceniv Referral Form |
